Scholarlink

Background <p>This study, led by the Egyptian Society for Microcirculation in Rheumatic Diseases, aimed to address the oversight of very early systemic sclerosis (SSc) as a pre-systemic sclerosis stage, hypothesizing that current clinical practices primarily focus on diagnosing SSc only when it meets established classification criteria. Identification of this patients’ cohort at such an early phase is a window of opportunity to treat those at high risk of skin fibrosis or organ involvement before such events occur.</p> Objective <p>The aim of this work was to establish a standardized, multidisciplinary clinic dedicated to the early assessment, diagnosis, and management of patients with very early systemic sclerosis (veSSc).</p> Methods <p>The methodology adhered to the PRISMA guidelines for reporting systematic reviews. To develop the clinical care standards framework, key clinical questions were systematically formulated using the PICO framework (Population, Intervention, Comparison, Outcome); a comprehensive literature review was conducted from 2010 to 2025 across multiple databases, and a geographically diverse task force of national experts was assembled to participate in a two-round Delphi process to assess consensus levels.</p> Results <p>Twelve key clinical questions were systematically developed using the PICO (Population, Intervention, Comparison, Outcome) framework. Following a review of the literature, and with the endorsement of the Egyptian Society for Microcirculation in Rheumatic Diseases, a Delphi process was carried out. Consensus was reached (i.e. ≥ 75% of respondents strongly agreed or agreed) on the wording, the grade of recommendation, and the level of evidence of all the clinical standards identified by the scientific committee.</p> Conclusion <p>Setting up a very early systemic sclerosis (veSSc) clinic involves establishing a system for early detection and management of SSc, focusing on patients with Raynaud’s phenomenon and other early symptoms. The goal is to identify individuals at risk of progressing to SSc and offer prompt, targeted interventions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The critical window of very early systemic sclerosis: a framework for a specialized early systemic sclerosis clinic

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月9日

查看全文
  • Yasser El Miedany,
  • Maha Elgaafary,
  • Mary Wadie,
  • Safaa Mahran,
  • Rahma A Elziaty,
  • Waleed Hassan,
  • Mohamed Hassan Abu-Zaid,
  • Yousra Hisham Abdel-Fattah,
  • Walaa Elwakil

摘要

Background

This study, led by the Egyptian Society for Microcirculation in Rheumatic Diseases, aimed to address the oversight of very early systemic sclerosis (SSc) as a pre-systemic sclerosis stage, hypothesizing that current clinical practices primarily focus on diagnosing SSc only when it meets established classification criteria. Identification of this patients’ cohort at such an early phase is a window of opportunity to treat those at high risk of skin fibrosis or organ involvement before such events occur.

Objective

The aim of this work was to establish a standardized, multidisciplinary clinic dedicated to the early assessment, diagnosis, and management of patients with very early systemic sclerosis (veSSc).

Methods

The methodology adhered to the PRISMA guidelines for reporting systematic reviews. To develop the clinical care standards framework, key clinical questions were systematically formulated using the PICO framework (Population, Intervention, Comparison, Outcome); a comprehensive literature review was conducted from 2010 to 2025 across multiple databases, and a geographically diverse task force of national experts was assembled to participate in a two-round Delphi process to assess consensus levels.

Results

Twelve key clinical questions were systematically developed using the PICO (Population, Intervention, Comparison, Outcome) framework. Following a review of the literature, and with the endorsement of the Egyptian Society for Microcirculation in Rheumatic Diseases, a Delphi process was carried out. Consensus was reached (i.e. ≥ 75% of respondents strongly agreed or agreed) on the wording, the grade of recommendation, and the level of evidence of all the clinical standards identified by the scientific committee.

Conclusion

Setting up a very early systemic sclerosis (veSSc) clinic involves establishing a system for early detection and management of SSc, focusing on patients with Raynaud’s phenomenon and other early symptoms. The goal is to identify individuals at risk of progressing to SSc and offer prompt, targeted interventions.